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The term cortical spreading depolarization (CSD) describes a wave of mass neuronal depolarization associated with net inﬂux of
cations and water. Clusters of prolonged CSDs were measured time-locked to progressive ischaemic damage in human cortex.
CSD induces tone alterations in resistance vessels, causing either transient hyperperfusion (physiological haemodynamic
response) in healthy tissue; or hypoperfusion [inverse haemodynamic response=cortical spreading ischaemia (CSI)] in tissue
at risk for progressive damage, which has so far only been shown experimentally. Here, we performed a prospective, multicentre
study in 13 patients with aneurysmal subarachnoid haemorrhage, using novel subdural opto-electrode technology for simulta-
neous laser-Doppler ﬂowmetry (LDF) and direct current-electrocorticography, combined with measurements of tissue partial
pressure of oxygen (ptiO2). Regional cerebral blood ﬂow and electrocorticography were simultaneously recorded in 417 CSDs.
Isolated CSDs occurred in 12 patients and were associated with either physiological, absent or inverse haemodynamic responses.
Whereas the physiological haemodynamic response caused tissue hyperoxia, the inverse response led to tissue hypoxia. Clusters
of prolonged CSDs were measured in ﬁve patients in close proximity to structural brain damage as assessed by neuroimaging.
Clusters were associated with CSD-induced spreading hypoperfusions, which were signiﬁcantly longer in duration (up to
144min) than those of isolated CSDs. Thus, oxygen depletion caused by the inverse haemodynamic response may contribute
to the establishment of clusters of prolonged CSDs and lesion progression. Combined electrocorticography and perfusion
monitoring also revealed a characteristic vascular signature that might be used for non-invasive detection of CSD. Low-
frequency vascular ﬂuctuations (LF-VF) (f50.1Hz), detectable by functional imaging methods, are determined by the brain’s
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ing depression of high-frequency-electrocorticography activity. Accordingly, we observed a spreading suppression of LF-VF,
which accompanied spreading depression of high-frequency-electrocorticography activity, independently of whether CSD was
associated with a physiological, absent or inverse haemodynamic response. Spreading suppressions of LF-VF thus allow the
differentiation of progressive ischaemia and repair phases in a fashion similar to that shown previously for spreading depres-
sions of high-frequency-electrocorticography activity. In conclusion, it is suggested that (i) CSI is a novel human disease
mechanism associated with lesion development and a potential target for therapeutic intervention in stroke; and that
(ii) prolonged spreading suppressions of LF-VF are a novel ‘functional marker’ for progressive ischaemia.
Keywords: CSI; subarachnoid haemorrhage; cortical spreading depression; neurovascular coupling; default mode
Abbreviations: aSAH=aneurysmal subarachnoid haemorrhage; BOLD=blood oxygen level dependent; COSBID=Cooperative
Study on Brain Injury Depolarizations; CSD=cortical spreading depolarization; CSI=cortical spreading ischaemia; CT=computed
tomography; DC=direct current; DSA=digital subtraction angiography; ECoG=electrocorticography; GCS=Glasgow Coma Score;
HF-ECoG=high-frequency electrocorticogram; HF-VF=high-frequency vascular ﬂuctuations; ICP=intracranial pressure;
LDF=laser-Doppler ﬂowmetry; LF-VF=low-frequency vascular ﬂuctuations; MCA=middle cerebral artery; MRI=magnetic
resonance imaging; MRS=Modiﬁed Rankin Scale; NMDA=N-methyl-D-aspartate; ptiO2=tissue partial pressure of oxygen;
rCBF=regional cerebral blood ﬂow; SPC=slow potential change; TCD=transcranial Doppler-sonography; WFNS=World
Federation of Neurological Surgeons.
Introduction
The term ‘cortical spreading depolarization’ (CSD) describes the
wave of near-complete neuronal depolarization and neuronal
swelling in the brain that is ignited when passive cation inﬂux
across the cellular membranes exceeds ATP-dependent sodium
and calcium pump activity. The cation inﬂux is followed by
water inﬂux and shrinkage of the extracellular space by 70%
(Kraig and Nicholson, 1978; Somjen, 2004). If the normal ion
homoeostasis is not restored through additional recruitment of
sodium and calcium pump activity, the cell swelling is
maintained––a process then termed ‘cytotoxic oedema’ (Klatzo,
1987) since it potentially leads to cell death through the protracted
intracellular calcium surge and mitochondrial depolarization.
Although the ignition of CSD occurs passively, driven by
electrical and diffusion forces, energy consumption paradoxically
increases since sodium and calcium pumps are immediately
activated to correct the intracellular sodium and calcium surge.
Thus, even in healthy tissue where CSD is fully reversible, ATP
immediately falls by 50% (Mies and Paschen, 1984). In order
to increase oxygen and glucose availability, CSD induces dilatation
of resistance vessels in healthy tissue. Hence, regional cerebral
blood ﬂow increases during the neuronal depolarization phase.
Only after the neuronal repolarization, the phase of vasodilatation
is followed by mild vasoconstriction resulting in spreading oligae-
mia (Lauritzen, 1994).
The opposite of this physiological haemodynamic response to
CSD is termed here the inverse haemodynamic response, and
occurs when there is local dysfunction of the microvasculature.
With the inverse response, severe microvascular spasm instead
of vasodilatation is coupled to the neuronal depolarization phase
(Dreier et al., 1998; Shin et al., 2006). The resulting spreading
perfusion deﬁcit in turn prolongs the neuronal depolarization [as
reﬂected by a prolonged negative shift of the extracellular direct
current (DC) potential] and the intracellular sodium and calcium
surge, since the oxygen-/glucose deprivation further reduces ATP
availability (Dreier et al., 1998, 2002; Sukhotinsky et al., 2008).
Thus, in animal experiments, a prolonged negative cortical DC
shift, the deﬁning electrophysiologic feature for the inverse
haemodynamic response, indicates that the hypoperfusion is sig-
niﬁcant enough to produce a mismatch between neuronal energy
demand and supply (Dreier et al., 1998, 2000, 2002; Sukhotinsky
et al., 2008). Accordingly, the term ‘cortical spreading ischaemia’
(CSI) describes the CSD-induced perfusion deﬁcit when it leads
to a prolonged negative cortical DC shift (Dreier et al., 1998,
2002).
In the presence of normal baseline perfusion, very prolonged,
pharmacologically induced CSI is sufﬁcient to produce widespread
focal necrosis (Dreier et al., 2000). This suggested that the inverse
haemodynamic response to CSD is: (i) a process by which CSD
increases the likelihood of inducing cell death and; thus, (ii) is a
promising target for therapeutic intervention (Dreier et al., 1998,
2000). CSI has been observed in a rat model replicating conditions
following aneurysmal subarachnoid haemorrhage (aSAH) (Dreier
et al., 1998), in rat models of hypotension and hypoxia
(Sukhotinsky et al., 2008), as well as in the penumbra after
middle cerebral artery (MCA) occlusion in mice and cats
(Shin et al., 2006; Strong et al., 2007).
Here, we investigated whether the full spectrum from physio-
logical to inverse haemodynamic responses occurs in the diseased
human brain in a fashion similar to that seen in animals.
Moreover, we studied whether CSD can be identiﬁed by a vascu-
lar signal that is independent of the perfusion change. For these
purposes, small optodes were integrated into subdural electrode
strips that allowed the simultaneous measurement of the electro-
corticogram (ECoG) with regional cerebral blood ﬂow using
laser-Doppler ﬂowmetry (LDF) in aSAH patients. Thus, the local
haemodynamic response to CSD was recorded at given opto-
electrode pairs on the surface of the human brain with high-spatial
and temporal resolution.
aSAH patients were studied since animal experiments suggested
a role for CSI in delayed ischaemia (Dreier et al., 1998). Moreover,
Cortical spreading ischaemia Brain 2009: 132; 1866–1881 | 1867delayed ischaemic stroke after aSAH is a model disease for ischae-
mic stroke and future intervention trials for two reasons. First, it is
the most important in-hospital complication after aSAH with
a peak occurrence around day 7, while the patient is already
on the intensive care unit (MacDonald et al., 2007).
Neuroprotectants have been shown to be most effective when
given either before, or within minutes after, the onset of acute
neuronal injury. Thus, delayed stroke allows administration of a
neuroprotectant prior to the possible insult, or very shortly there-
after, to prove or disprove the concept. Second, neurosurgical
procedures are indicated early after the initial haemorrhage and
allow placement of invasive probes. This provides the unique
option to monitor invasively the whole period of ischaemic
stroke development.
Materials and Methods
Patient recruitment and clinical care
Thirteen patients with major aSAH were recruited by four centres of
the Cooperative Study on Brain Injury Depolarizations (COSBID, see
www.cosbid.org): Campus Charite ´ Mitte Berlin (n=9), Campus
Benjamin Franklin Berlin (n=2), King’s College London (n=1), and
Glostrup Hospital Copenhagen (n=1). The research protocol was
approved by the local ethics committees. Clinical and research
consents were obtained according to the Declaration of Helsinki
after a clinical decision had been taken to offer surgical treatment.
aSAH was diagnosed by assessment of CT scans. Haemorrhage was
graded according to the Fisher scale, and clinical presentation accord-
ing to the World Federation of Neurological Surgeons (WFNS) scale.
The indications for neurosurgical treatment are given in Table 1.
Surgery allowed the placement of a single, linear, 6-contact (platinum)
electrocorticography recording strip (Wyler, 5-mm diameter; Ad-Tech
Medical, Racine, Wisconsin, USA) on cortex accessible through the
craniotomy or via an extended burr-hole (Dreier et al., 2006;
Fabricius et al., 2006). Four optodes neighbouring electrodes 3–6
were integrated in the recording strip for LDF (Perimed AB, Ja ¨rfa ¨lla,
Sweden). After surgery, patients were transferred to the intensive
care unit. Intracranial pressure (ICP) was monitored via ventricular
drainage catheter in 12 of the 13 patients. Glasgow Coma Score
(GCS), blood gases, glucose and electrolytes were documented
every 6h. A thorough neurological examination was performed at
least daily. Serial CT scans were performed postoperatively at the
time of clinical deterioration and after the monitoring period to
screen for delayed infarcts. Vasospasm was deﬁned using digital
subtraction angiography (DSA) as 430% narrowing of the arterial
luminal diameter in one of the following arterial segments: A1, A2,
M1, M2 and C1–C2. Magniﬁcation errors were corrected by compar-
ing extradural segments of the internal carotid artery (C4–C5). Using
transcranial Doppler-sonography (TCD), signiﬁcant vasospasm was
deﬁned by a mean velocity 4200cm/s in at least one MCA and
vasospasm was excluded if the MCA mean velocities remained
below 120cm/s throughout the observation period. Patients with
delayed ischaemia were treated with triple-H therapy (hypertension,
hypervolaemia and haemodilution) as described previously (Dreier
et al., 2006). Oral nimodipine was given prophylactically in all
patients with aSAH.
Electrocorticography and LDF using
subdural opto-electrode strips
Electrocorticography recordings were acquired continuously in ﬁve
active channels from the 6-electrode (linear array) subdural strips.
Electrode 1 served as ground, while electrodes 2–6 (interelectrode
distance 1cm) were connected in sequential unipolar fashion to a
GT205 ampliﬁer (0.01–50Hz) (ADInstruments, New South Wales,
Australia), each referenced to an ipsilateral subgaleal platinum elec-
trode. The DC-electrocorticography was additionally recorded using
a BrainAmp ampliﬁer (0–50Hz) (BrainProducts GmbH, Munich).
Data were sampled at 200Hz and recorded and reviewed with the
use of a Powerlab 16/SP analog/digital converter, Chart-5 software
(ADInstruments, New South Wales, Australia) and BrainVision
Recorder software (BrainProducts GmbH, Munich), respectively. The
tissue partial pressure of oxygen (ptiO2) was recorded in eight patients
using an intraparenchymal oxygen sensor (Licox, Integra Lifesciences
Corporation, Plainsboro, NJ, USA).
Data analysis
CSD was deﬁned by the sequential onset in adjacent channels of
a propagating slow potential change (SPC) (Fabricius et al., 2006). The
parallel high-frequency-electrocorticography depression was a priori
deﬁned by a rapidly developing reduction of the power of the
electrocorticogram (ECoG) amplitude by at least 50%. The duration of
the depression period of the high-frequency-electrocorticography
activity was measured as the interval between depression onset and
onset of restoration of activity using the integral of power of the
band-pass ﬁltered activity (time constant decay, 60s) as described
previously (Dreier et al., 2006).
The high-frequency-electrocorticography was split into differ-
ent frequency bands roughly according to classically deﬁned
electroencephalographic conventions (Leopold et al., 2003) comprising
the following ranges: sub-d (0.5–1Hz), d (1–4Hz), y (5–8Hz), a
(9–14Hz), b (15–30Hz) and gL (30–50Hz). Regional cerebral blood
ﬂow was simultaneously recorded in the full-band between 0 and
10Hz using LDF. The full-band of the regional cerebral blood ﬂow
signal is dominated by baseline changes in the frequency range from
0 to 0.05Hz on which low-frequency vascular ﬂuctuations (LF-VF)
(0.05–0.1Hz) and high-frequency vascular ﬂuctuations (HF-VF)
(0.5–10Hz) are superimposed. As demonstrated in Fig. 1, the HF-VF
are dominated by the microcirculatory pulse since they are coherent
with the systemic arterial pressure variations as recorded invasively in
the radial artery (n=7 patients).
For the analysis of isolated CSD, the curves were ﬁrst screened
for recording periods containing CSDs with at most minor artefacts.
Then, the isolated CSD of each patient was selected with the
longest depression period of the high-frequency-electrocorticogram
(HF-ECoG) activity, since the study focused on the consequences of
energy compromise and it is assumed that a prolonged duration of the
HF-ECoG depression is an indicator of energy depletion in the animal
and human brain (Nedergaard and Hansen, 1993; Back et al., 1994;
Dreier et al., 2006; Fabricius et al., 2006). Thereafter, the opto-
electrode pair was taken for analysis that demonstrated a large SPC
indicating appropriate positioning of this particular electrode on the
cortex and a regional cerebral blood ﬂow signal with well-expressed
HF-VF (pulse). This procedure resulted in 12 recordings of an isolated
CSD for the statistical comparison. Data are given as median (ﬁrst,
third quartile). The statistical tests used are speciﬁed in the text.
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Cortical spreading ischaemia Brain 2009: 132; 1866–1881 | 1869Eight of the 12 patients were sedated and 10 were ventilated during
the single CSD taken for analysis. Thus, the recorded GCS was only 3
(3, 6), which probably underestimated the clinical status that would
have been observed without sedation. The following vital signs and
paraclinical parameters were documented during the CSD (n=12):
temperature [37.2 (36.3, 37.7)C], mean arterial pressure [96 (93,
98)mmHg], intracranial pressure [17 (16, 18)mmHg], cerebral
perfusion pressure [78 (74, 82)mmHg], pH [7.44 (7.42, 7.44)], pCO2
[39.0 (35.3, 41.8)mmHg], oxygen saturation [98.5 (97.9, 99.2)%],
serum glucose [120 (107, 148)mg/dl], serum lactate [7 (6, 9)mg/dl],
haematocrit [29.5 (28.9, 32.2)%], serum sodium [143 (140,
147)mmol/l] and serum potassium [4.2 (3.7, 4.3)mmol/l]. Eight of
12 patients received noradrenaline intravenously [median dose: 0.11
(0.07, 0.22)mg/kgBW/min]. Continuous recordings of intracranial
pressure and arterial pressure were performed in seven patients without
signiﬁcant change during the CSD. The resting ECoG activity was
characterized by a burst suppression pattern in six cases and dominated
by sub-d-i n3 ,d- in 2 and y-activity in one case [median peak to peak
amplitude of resting ECoG activity: 368 (256, 409)mV].
Limitations of the set-up
We applied the combination of DC-ECoG and LDF technology,
hitherto used only in experimental animals. This combination repre-
sents the gold standard for identiﬁcation of the physiological and
inverse haemodynamic responses to CSD in animals (Dreier et al.,
1998). The choice of the opto-electrode strip was justiﬁed since:
(i) no modiﬁcation of the surgical procedure was necessary compared
to a recording strip without optodes; (ii) the use of a single, narrow
linear electrode strip allowed withdrawal at the bedside; (iii) no infec-
tious or haemorrhagic complications were encountered and (iv) the
use of the opto-electrode strips clearly allowed identiﬁcation of
physiological and inverse haemodynamic responses to CSD, respec-
tively. However, there were some limitations compared with animal
experiments. The optodes were more delicate, the monitoring period
was signiﬁcantly longer, and the nursing procedures required in inten-
sive care necessarily involve patient movement. Therefore, even with
great care, breaks of the ﬁne light ﬁbres may occur. Furthermore, the
opto-electrode pairs cannot be placed over regions of interest under
visual control. Therefore, in most patients only one or two of the four
optodes yielded a stable signal of sufﬁcient quality. Moreover, during
continuous monitoring over days, movement artefacts produce base-
line shifts, and a zero ﬂow value cannot be obtained in a living human
being. Therefore, changes of regional cerebral blood ﬂow during CSD
were only calculated in relation to regional cerebral blood ﬂow imme-
diately before CSD and only the pattern of regional cerebral blood
ﬂow changes was assessed. LDF and ECoG were closely adjacent
but not recorded at exactly the same site, thus limiting the precision
of temporal correlations between the two.
Results
Table 1 gives a summary of the clinical and monitoring character-
istics of the 13 patients studied. CSD occurring in temporal clusters
and in isolation were analysed separately (see Materials and
Methods section). Twelve patients showed isolated CSDs, which
were characterized by a SPC of 3.4 (1.9, 5.3)mV (high-pass ﬁlter
with lower frequency limit: 0.01Hz). The ‘true’ DC potential
(lower frequency limit: 0Hz) was measured in eight patients
during isolated CSDs [negative shift: –10.8 (9,7, 13,7)mV;
duration: 153 (123, 283)s]. CSD propagation velocity was 2.1
(1.8, 2.9)mm/min assuming an ideal linear spread along the
recording strip. Figure 2A gives an original recording of a negative
DC shift associated with CSD propagating from opto-electrode
6–4 at a velocity of 1.9mm/min. Note the remarkable similarity
of the negative DC shift (19mV at electrode 6) to animal ﬁnd-
ings (Lauritzen, 1994). Figure 2B allows a direct comparison
between the ‘true’ negative DC shift (1) and its distorted mani-
festation as a smaller SPC in recordings with a lower frequency
limit of 0.01Hz (Trace 2).
Figure 1 Obvious coherences (i) between high-frequency-ECoG activities at different electrodes, (ii) between LF-VF at different
optodes and (iii) between HF-VF, arterial pulse and intracranial pressure ﬂuctuations. The ECoG shows a burst suppression pattern
(Case 10).
1870 | Brain 2009: 132; 1866–1881 J. P. Dreier et al.Figure 2 Spreading depression of high-frequency-ECoG activity and spreading suppression of LF-VF correlate in the human brain
during physiological and absent haemodynamic responses to CSD, respectively. (A) On the upper right, the opto-electrode strip is
shown. The 12 traces represent simultaneous recordings of a single CSD (Case 7) that propagated from opto-electrode 6 (Traces 1–6)
to 4 (Traces 7–12). The calibration bars at opto-electrode 4 (Traces 7–12) also apply to the corresponding traces at opto-electrode 6
(Traces 1–6). Opto-electrode 6: the ﬁrst three traces identify the CSD electrophysiologically. Trace 1 (black): full-band ECoG changes
including the negative DC potential; Trace 2 (light blue): depression of high-frequency-ECoG activity (d-band); Trace 3 (green): integral
of power of the d-band, used to calculate the depression period. Trace 4 (brown) (full-band regional cerebral blood ﬂow signal):
displays a ﬂow increase characteristic of the physiological haemodynamic response to CSD. LF-VF (0.05–0.1Hz) and HF-VF (0.5–10Hz)
are contained in the full-band regional cerebral blood ﬂow signal. During CSD, the LF-VF (Trace 5) became suppressed, while the
HF-VF (Trace 6) increased underscoring their differential nature (HF-VF=pulse). Note that the LF-VF recovery (Trace 5) starts at a
similar moment as the recovery of the high-frequency-ECoG (Trace 2). Opto-electrode 4: the CSD spread from opto-electrode 6–4at
a rate of 1.9mm/min. The changes at opto-electrode 4 are similar to those at opto-electrode 6. Importantly, note simultaneous
propagation of the spreading suppression of LF-VF and the spreading depression of high-frequency-ECoG. (B) The 14 traces represent
simultaneous recordings of a single CSD (Case 3) at opto-electrode 5. The nine traces of the upper part identify the CSD
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physiological or absent haemodynamic
responses
Four of the 12 isolated CSDs analysed were rated to display a
physiological haemodynamic response, since the initial response
was predominantly hyperaemic. Hyperaemia reached a level of
257 (211, 311)% lasting for 689 (512, 812)s followed by spread-
ing relative oligaemia to 92 (79, 102)%. The SPC preceded the
initial spreading hyperaemia by 47 (37, 235)s. Figure 2A demon-
strates an original recording of an isolated CSD with physiological
haemodynamic response (Case 7). Another three of the 12 CSDs
did not show any signiﬁcant change in level of regional cerebral
blood ﬂow at all. This behaviour was rated as absent haemody-
namic response (Case 3, Fig. 2B).
Isolated CSDs can be associated with
inverse haemodynamic responses
Figure 3A shows an example of the inverse haemodynamic
response to CSD (Case 8) which was observed in the remaining
5 of 12 isolated CSDs. Based on previous experimental work, the
following observations characterized this inverse response or CSI:
(i) The DC potential change preceded the initial hypoperfusion by
65 (16, 83)s; (ii) the local hypoperfusion was characterized by a
fall of regional cerebral blood ﬂow to 59 (31, 62)% lasting for 118
(88, 265)s that did not start in a step-like fashion as in a cardiac
arrest or embolic occlusion, but rather gradually reached the
trough within 90s; (iii) the local hypoperfusion propagated with
the cortical DC potential negativity in the tissue at a rate of
3.5 (1.6, 3.5)mm/min (in Fig. 3A propagation from opto-
electrode 3–5 is shown); (iv) including all eight CSDs with
simultaneous recordings of regional cerebral blood ﬂow and DC
potential, linear regression found that the durations of the initial
hypoperfusion and the cortical DC potential negativity were highly
signiﬁcantly correlated [Fig. 3B, R=0.92, P50.001, n=8, com-
pare Dreier et al. (2002) and Sukhotinsky et al. (2008) for this
linear regression in rat recordings]; (v) moreover, linear regression
demonstrated that the durations of the cortical DC potential
negativity and the energy-dependent recovery of the HF-ECoG
activity were highly correlated (Fig. 3C, R=0.93, P50.001,
n=8); ﬁnally (vi) linear regression demonstrated a highly signiﬁ-
cant correlation between initial changes in level of regional
cerebral blood ﬂow and ptiO2 in response to CSD (Fig. 4D,
R=0.84, P=0.019, n=7). Figure 4A gives an example of spread-
ing hyperoxia (arrows) associated with a physiological haemo-
dynamic response to CSD. Figure 4B shows spreading hypoxia
(arrows) associated with an inverse haemodynamic response to
CSD, supporting the hypothesis that CSI leads to signiﬁcant reduc-
tion of energy substrate availability. Figure 4C shows an epileptic
seizure associated with physiological haemodynamic response and
hyperoxia (arrow) for comparison.
Spreading suppressions of
low-frequency vascular ﬂuctuations
correlate with HF-ECoG depressions,
not perfusion changes
Baseline changes in vascular smooth muscle tone of resistance
vessels essentially determine the level of local tissue perfusion.
LF-VF occur superimposed on the baseline changes in vascular
tone and level of perfusion, while HF-VF represent the pulse
and are superimposed on the LF-VF (Fig. 1).
We found that LF-VF were suppressed during CSD regardless of
the perfusion response. In the case of the physiological haemo-
dynamic response to CSD illustrated in Fig. 2A (Case 7), a spread-
ing suppression of LF-VF (traces 5 and 11, respectively) in both
opto-electrode Pairs 6 and 4 was time-locked to the spreading
depression of high-frequency-ECoG activity (Traces 2 and 8,
respectively). Figure 2B (Case 3) shows an example for the
absent haemodynamic response to CSD. Despite the absent perfu-
sion response, the LF-VF became transiently suppressed. Spreading
suppression of LF-VF also accompanied spreading depression of
high-frequency-ECoG activity during the inverse haemodynamic
response to CSD (Fig. 3D).
It has been suggested that LF-VF arise from the resting neuronal
activity which is reﬂected in the high-frequency-ECoG (Biswal
et al., 1995; Fox and Raichle, 2007). If this hypothesis is correct,
then the spreading suppression of LF-VF should correlate with the
spreading depression of high-frequency-ECoG induced by CSD.
electrophysiologically. The ﬁve traces of the lower part characterize the regional cerebral blood ﬂow response, remarkable for only a
very marginal increase of regional cerebral blood ﬂow (absent haemodynamic response to CSD). Upper part: Trace 1 (black): full-band
ECoG changes of CSD including DC potential; Traces 2–9 (different shades of blue and green): different frequency bands contained in
the full-band signal of Trace 1. The frequency band of 0.01–0.05Hz (Trace 2) has been used previously to identify the SPC in the
human brain (Dreier et al., 2006; Fabricius et al., 2006). The advantage of the (unﬁltered) DC potential over this frequency band is that
the duration of the DC negativity is a summary measure that reﬂects the time period until the energy dependent repolarization.
The depression of ECoG activity is best seen in the higher frequency bands [d (Trace 5), y (Trace 6), a (Trace 7), b (Trace 8) and gL
(Trace 9)], whilst it is less obvious in the lower frequency bands (traces 3 and 4). Lower part: Trace 10 (brown) (full-band regional
cerebral blood ﬂow signal): displays no signiﬁcant perfusion change (absent haemodynamic response to CSD). Traces 11–14: different
frequency bands contained in the full-band signal of regional cerebral blood ﬂow. Note the strong suppression of the LF-VF (Trace 12,
orange) despite the absence of a signiﬁcant perfusion change in Trace 10. Also note that the durations of the suppression of LF-VF
(solid horizontal bar, Trace 12) and the depression of high-frequency-ECoG activity (d-gL frequency bands, broken horizontal bars,
Traces 5–9) are similar. Also note that the durations of the depression periods of LF-VF and HF-ECoG are signiﬁcantly longer in
(B) (absent haemodynamic response to CSD) compared with (A) (physiological haemodynamic response to CSD) consistent with the
notion that the recovery of synaptic activity depends on energy supplied by regional cerebral blood ﬂow.
1872 | Brain 2009: 132; 1866–1881 J. P. Dreier et al.Figure 3 Inverse haemodynamic response to CSD. (A) On the upper right, the opto-electrode strip is shown. The six traces represent
simultaneous recordings of a single CSD with inverse haemodynamic response (Case 8) that propagated from opto-electrode 3 (Traces
1–3) to 5 (Traces 4–6). Note that the CSD-induced initial hypoperfusion at optode 5 lasts for 4.9min and is associated with a prolonged
negative DC shift lasting for 9.9min. The prolongation of the direct current negativity renders this hypoperfusion a CSI, meaning that it
produces a delay of the energy dependent recovery from the extracellular direct current negativity (reﬂecting intracellular sodium and
calcium surge). Note that the durations of direct current negativity and CSD-induced hypoperfusion are similar at opto-electrode 5 and
markedly longer lasting than those at opto-electrode 3. (B) Linear regression showing that the durations of initial hypoperfusion and
cortical DC negativity are correlated [compare (A)]. (C) Linear regression showing that the durations of cortical DC potential negativity
and energy-dependent recovery of high-frequency-ECoG activity are correlated. (D) Fourteen traces showing simultaneous recordings
of a single CSD (Case 11) at opto-electrode 3 associated with inverse haemodynamic response. The nine traces of the upper part
identify the CSD electrophysiologically similarly as in Fig. 2B. The ﬁve traces of the lower part characterize regional cerebral blood ﬂow.
The duration of CSI (Trace 10, brown) was 2min, the duration of the negative DC shift (Trace 1, black) 4.5min. Note simultaneous
long-lasting depression of high-frequency-ECoG activity (broken horizontal bars in Traces 5–9) and suppression of LF-VF (solid
horizontal bar in Trace 12, orange).
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sion of high-frequency-ECoG activity in the sub-d, d-, y-, a-, b-
and gL frequency bands, but not in frequencies below 0.5Hz
(Repeated measures ANOVA on ranks with Dunn’s post hoc
test, n=12, P50.05) (Fig. 5A). For example, the d-power signiﬁ-
cantly decreased from 909 (498, 1734) to 195 (86, 575)mV
2 fol-
lowed by a signiﬁcant recovery to 920 (473, 1508)mV
2 (Repeated
measures ANOVA on ranks with Dunn’s post hoc test, n=12,
P50.05).
LF-VF (0.05–0.1Hz) was observed in 10 of 12 cases. The
median frequency of the LF-VF was 0.079 (0.070, 0.091)Hz.
During CSD, LF-VF became signiﬁcantly suppressed (Repeated
measures ANOVA on ranks with Dunn’s post hoc test, n=10,
P50.05) (Fig. 5A). The power of the LF-VF robustly and signiﬁ-
cantly decreased from 128.3 (88.4, 199.2) to 2.8 (2.0, 7.8) LDF
U
2 followed by a signiﬁcant recovery to 99.7 (47.3, 206.2) LDF U
2
after CSD (Repeated measures ANOVA on ranks, n=10,
P50.05). The degree of LF-VF suppression was not signiﬁcantly
different between CSDs with different haemodynamic responses.
No signiﬁcant difference was detected between the durations of
the spreading suppressions of LF-VF [428 (320, 847)s] and high-
frequency-ECoG activity [sub-d: 943 (578, 1290)s, d: 660 (470,
843)s, y: 660 (538, 854)s, a: 750 (622, 1030)s, b: 678 (539,
957)s, gL: 340 (239, 1069)s, Repeated measures ANOVA on
ranks, n=7]. Importantly, the durations of the spreading suppres-
sion of LF-VF and spreading depression of high-frequency-ECoG
activity correlated signiﬁcantly [Linear regression with sub-d
(R=0.70, P=0.026, n=10), d (R=0.91, P50.001, n=10,
Fig. 5B), y (R=0.84, P=0.005, n=9), a (R=0.88, P=0.004,
n=8), b (R=0.87, P=0.002, n=9), gL (R=0.93, P50.001,
n=8)].
HF-VF follow the perfusion change
The HF-VF followed changes in perfusion, whether the predomi-
nant response to CSD was hyperaemia (Fig. 2A, Traces 6 and 12)
or hypoperfusion (Fig. 3D, Trace 14). Including all 12 CSDs, linear
regression found that the mean change in power of the HF-VF
Figure 4 The physiological haemodynamic response to CSD is associated with spreading hyperoxia, whilst the inverse haemodynamic
response is associated with spreading hypoxia. (A) Three CSDs are shown (Case 12) characterized by a SPC (Trace 1, blue line, lower
frequency limit 0.01Hz), a short-lasting depression of the high-frequency-ECoG activity (Trace 2, green), initial hyperaemia (Trace 3,
brown, physiological haemodynamic response to CSD) and tissue hyperoxia (Trace 4, black, arrows). (B) Two CSDs are shown
(Case 11) characterized by a SPC (Trace 1, blue), a longer-lasting depression of the high-frequency-ECoG activity (Trace 2, green), CSI
(Trace 3, brown, inverse haemodynamic response to CSD) and tissue hypoxia (Trace 4, black, arrows). (C) A seizure is given (Case 4)
with only minor SPC (Trace 1) compared with that of a CSD, rhythmic 4/s d-activity (amplitude: 700mV) (Trace 2), hyperaemia (Trace
3) and hyperoxia (Trace 4, arrow). (D) Linear regression showing correlation between the initial changes in level of regional cerebral
blood ﬂow and parenchymal ptiO2 in response to CSD.
1874 | Brain 2009: 132; 1866–1881 J. P. Dreier et al.highly signiﬁcantly correlated with the mean change in perfusion
associated with CSD (Fig. 5C, R=0.94, P50.001, n=12).
Clusters of recurrent CSDs with
prolonged depression of low-frequency
vascular ﬂuctuations
Clusters without recovery of high-frequency-ECoG activity
between the recurrent CSDs were identiﬁed in Cases 1–5.
During clusters, all patients were comatose with GCS 56 and
ventilated. Three patients were sedated (Table 1). No signiﬁcant
difference was found in vital signs, paraclinical parameters or
noradrenaline administration between isolated CSDs and clusters,
except that intracranial pressure was signiﬁcantly higher during
clusters [21 (20, 22) versus 17 (16, 18)mmHg, Mann–Whitney
Rank Sum Test, P=0.031].
The CSDs contained in a cluster were characterized by a SPC of
2.7 (2.2, 2.7)mV (lower frequency limit: 0.01Hz). The propaga-
tion velocity of CSD was 3.8 (1.6, 4.5)mm/min. The clusters
consisted of 6 (5, 8) CSDs that occurred at a median frequency
of 2.6 (2.0, 3.6)events/h. Clusters of recurrent CSDs were
associated with signiﬁcant depression of high-frequency-ECoG
power. For example in the d-band, the power signiﬁcantly
decreased from 483 (368, 671) to 64 (55, 76)mV
2 followed by
an insigniﬁcant recovery to 413 (158, 554)mV
2 (Repeated mea-
sures ANOVA on ranks, P50.05, n=5). The whole depression
period lasted for at least 60h in Case 1. In the remaining four
cases, the median depression period was 171 (136, 209)min as
assessed for the d-band.
All clusters contained CSDs associated with inverse haemo-
dynamic response in at least one optode. CSD induced a fall
of regional cerebral blood ﬂow to 67 (38, 70)% followed by
long-lasting, shallow hyperaemia. Similar to the isolated CSDs,
the SPC preceded the initial hypoperfusion by 89 (29, 109)s,
indicating that the CSD induced the hypoperfusion and not vice
versa. The median duration of the longest CSD-induced initial
hypoperfusion contained in a cluster was 24.5 (10.9, 27.7)min.
This was signiﬁcantly longer than the longest CSD-induced
initial hypoperfusion measured during isolated CSDs [2.0
(1.5, 4.4)min, Mann–Whitney Rank Sum Test, P=0.016, n=5
in each group].
An example of CSI in a CSD cluster is given in Figs 6 and 7. This
CSI occurred in Case 1 on Day 9 after aSAH during a delayed
cluster of recurrent, possibly cycling CSDs (Koroleva and Bures,
1979) in presence of the N-methyl-D-aspartate (NMDA) receptor
antagonist (S)-ketamine at 2mg/h. The cluster was possibly trig-
gered by hypoglycaemia, since a blood glucose level of 40mg/dl
was measured 2h and 40min after the onset. Moreover, TCD and
DSA had revealed signiﬁcant proximal vasospasm. Figure 6A
illustrates that the SPC and depression of high-frequency-ECoG
activity preceded the onset of the sharp hypoperfusion at
optode 4. If the SPC had been the consequence of the regional
cerebral blood ﬂow decline, it should have followed the regional
cerebral blood ﬂow decline by 2.5–5min according to previous
experimental ﬁndings (Lea ˜o, 1947). The propagation rate of SPC
and regional cerebral blood ﬂow from opto-electrodes 4–5 was
4.9mm/min (Fig. 6A). Compared with the level at cluster onset,
regional cerebral blood ﬂow fell to a minimum value of 6 and 3%
at opto-electrodes 4 and 5, respectively; the CSI lasted for 2h
24min and 1h 42min, respectively. Compared with the CTs of
Days 0, 1, 2 and 6 with only oedema, new widespread hypoden-
sities typical of delayed ischaemic infarcts after aSAH were seen on
the CT of Day 12 including the recording areas of opto-electrodes
4 and 5 (Fig. 7). After the CSI, the high-frequency-ECoG activity
remained depressed at electrodes 3–5, indicating permanent
ischaemic loss of neuronal function despite delayed reperfusion
(Fig. 7).
PtiO2 was recorded in Cases 1, 4 and 5 during clusters. In all
three cases, a progressive sustained reduction of ptiO2 developed
from a median value of 24.7–11.4mmHg with a median recovery
to 17.3mmHg after the cluster.
LF-VF preceded the clusters in only three of ﬁve cases. The
dominant frequency was 0.063 (0.021, 0.072)Hz. The power of
Figure 5 Spreading depression of high-frequency-ECoG
activity and spreading suppression of LF-VF correlate in
the human brain. (A) CSD-induced spreading depression is
signiﬁcant in the high-frequency bands of the ECoG and
spreading suppression in the low-frequency bands of regional
cerebral blood ﬂow. (B) The durations of spreading suppression
of LF-VF and spreading depression of high-frequency-ECoG
correlate. (C) The mean initial change of HF-VF correlates with
the mean initial perfusion change in response to CSD. Thus,
HF-VF might be a simple measure to estimate the perfusion
change in response to CSD using non-invasive recording
technology. The ﬁndings were similar if the bandwidth of
HF-VF was limited to 0.5–2Hz, more suitable for non-invasive
technologies with lower sampling rates.
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1370.3) to 3.4 (2.1, 6.5) LDF U
2 (Fig. 6B) followed by a recovery
to 63.4 (32.1, 71.1) LDF U
2 after the cluster. The duration of the
depression period of the LF-VF ranged from 211min to at least
60h, similar to that of the high-frequency-ECoG activity. As
shown in Fig. 6B, the changes of the HF-VF (Trace 6) followed
the perfusion changes (Trace 5) during the cluster of recurrent
CSDs, as in the case of isolated CSDs.
Figure 6 CSI in the human brain (same CSI as in Fig. 7 at higher temporal resolution). (A) Note the spreading SPC from electrode
4 (Trace 2, blue) to 5 (Trace 1, red) (velocity of 4.8mm/min). The onsets of the negative SPC (Trace 2) and depression of the high-
frequency-ECoG activity (Trace 4) at electrode 4 clearly preceded the onset of the steep decline of regional cerebral blood ﬂow at
optode 4 (Trace 6). If SPC and ECoG depression had been the consequence of the steep regional cerebral blood ﬂow decline, they
should have followed it with a delay of 2.5–5min (Lea ˜o, 1947). At opto-electrode 5, the high-frequency-ECoG activity (Trace 3) was
already depressed from a previous CSD and the SPC (Trace 1) was rather small. Importantly, the steep decline of regional cerebral
blood ﬂow propagated from optode 4 (Trace 6) to 5 (Trace 5) at a characteristic rate of 4.9mm/min (arrows). The spread was also
visible in the suppressions of the LF-VF (traces 7 and 8) and HF-VF (traces 9 and 10). The suppressions of the HF-VF (traces 9 and 10)
developed steeply but not in a step-like fashion contrasting other ischaemic aetiologies such as thread occlusion, embolism or cardiac
arrest. (B) Lower time resolution than (A) showing the parallel, progressive suppression of the LF-VF (Trace 4) and depression of the
high-frequency-ECoG activity (traces 2 and 3) at opto-electrode 4 during the cluster of CSDs resulting in CSI (Trace 5). Some
suppression/depression precedes the appearance of the ﬁrst SPC (Trace 1) reﬂected in both LF-VF and high-frequency-ECoG activity.
TRACE 6 shows the HF-VF correlating with the changes in level of regional cerebral blood ﬂow.
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Six hundred and three CSDs were recorded in 2467h recording
time in 13 patients. Pooling of all CSDs with simultaneous record-
ings of regional cerebral blood ﬂow and ECoG (1953h recording
time) resulted in 295 of 417 CSDs with no initial hypoperfusion
430s, whereas 78 CSDs showed an initial hypoperfusion between
30s and 2min, 16 between 2 and 5min and 28 of 45min up to
144min in at least one opto-electrode pair.
Discussion
Using combined invasive recordings of regional cerebral blood
ﬂow and regional DC-ECoG, we found that CSDs can be asso-
ciated with either physiological, absent or inverse haemodynamic
responses in the human brain. The regional cerebral blood ﬂow
response to CSD effected corresponding ptiO2 changes, suggest-
ing that the haemodynamic response is critical for energy avail-
ability during CSD. CSD clusters induced longer CSIs than isolated
Figure 7 CSI in the human brain (at lower temporal resolution than in Fig. 6). On Day 9, this 62-year-old patient suddenly developed
a cluster of CSDs. The position of the original recording strip in relation to the skull is shown in the left lower corner. The upper four
traces show the SPCs of electrodes 5–2. The next four traces represent the high-frequency-ECoG activity. Note that the cluster
paradoxically started at electrode 2 with only short-lasting depression period and no infarct demarcation in the CT of Day 12. The
further complex propagation of the CSDs is illustrated by the arrows. Traces 9–11: regional cerebral blood ﬂow changes at optodes 5–3.
The stars indicate the onset of CSI (compare Fig. 6A for higher temporal resolution). Note the long-lasting CSI at optodes 4 and 5 in
response to CSD at electrodes 4 and 5. The CSI is accompanied by local decrease of ptiO2 (Trace 12). After CSI the high-frequency-
ECoG activity remained depressed at all electrodes apart from electrode 2 (traces 5–8) corresponding with permanent ischaemic loss of
neuronal function. Compared to the CTs of Days 2 and 6 with only oedema, the CT of Day 12 showed new hypodensities typical of
delayed ischaemic infarcts including the recording areas of opto-electrodes 4 and 5 (right lower corner). This suggested that the
recorded hypoperfusion had reached the ischaemic range. The oedema on the CT of Day 6 was already seen on the CTs of Days 0,
1 and 2 suggesting that the initial haemorrhage was the cause. CT cannot differentiate whether the nature of this oedema was
vasogenic or cytotoxic. Thus, early ischaemic damage remains a possibility and the images do not provide deﬁnitive evidence that the
demarcated infarcts on the CT of Day 12 only developed between Days 6 and 12. However, if the tissue had not been viable before
the CSI on Day 9, it would not have displayed ECoG activity. Furthermore, a process of infarct demarcation over a period of more than
6 days would be unusual.
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to the establishment of such clusters. Spreading suppressions of
LF-VF always accompanied spreading depressions of high-
frequency-ECoG activity, regardless of the perfusion change.
Suppressions of LF-VF persisted for the full duration of depressions
of high-frequency-ECoG during CSD clusters. Such clusters were
associated with evidence of either early or delayed structural
damage on neuroimaging, as reported previously (Dreier et al.,
2006), and no delayed structural damage occurred in the record-
ing area in the absence of such clusters (Dreier et al., 2006).
The negative DC shift of CSD
In the present study, a robust invasive technology was introduced
to measure the negative DC potential shift of CSD in the human
brain. The invasive DC recordings using polarizable platinum elec-
trodes were remarkably stable, as shown in the ﬁgures, and were
possible through use of an ampliﬁer without lower frequency limit.
In animals, CSD is associated with the largest of all cerebral DC
shifts, exceeding that of epileptic seizures by 10-fold. Here, we
found similar amplitudes in the human brain of up to 20mV.
In animals, the negative DC shift of CSD provides an electrophy-
siological summary measure for the local pathological ion
imbalance with net inﬂux of sodium, calcium and water and,
thus, for the neuronal injury (Kraig and Nicholson, 1978;
Somjen, 2004). Whereas its amplitude reﬂects the sum of neurons
affected, its duration indicates the local cellular capacity to escape
from the detrimental cascades initiated by CSD including intracel-
lular sodium and calcium surge, mitochondrial depolarization and
extracellular glutamate accumulation that eventually lead to cell
death. Of note, whereas CSDs associated with short-lasting DC
negativities in healthy tissue are not harmful and are sensitive to
NMDA receptor blockers, CSDs associated with longer-lasting DC
negativities under pathological conditions become increasingly
detrimental and pharmacoresistant due to recruitment of addi-
tional cation channels (Mu ¨ller and Somjen, 1998).
Clinical implications of CSD
neuromonitoring
Diffusion-weighted imaging is applied clinically for early detection
of the protracted cytotoxic oedema, but is unsuitable to determine
online where, when and how the brain makes the transition from
health into injury, and from injury into repair (Lo, 2008). However,
the electrophysiological signature of CSD has been identiﬁed using
subdural recording strips for ECoG in patients with traumatic and
spontaneous intracerebral haematoma (Fabricius et al., 2006).
Using subdural ECoG and serial neuroimaging, it has been found
that clusters of recurrent CSDs with prolonged depression of
high-frequency-ECoG activity were time-locked to the local devel-
opment of delayed ischaemic stroke after aSAH (Dreier et al.,
2006). Patients with malignant hemispheric stroke similarly
showed a high incidence of clusters of recurrent CSDs with
prolonged high-frequency-ECoG depression (Dohmen et al.,
2008). Thus, it is suggested that monitoring of CSD could be
used clinically to differentiate between the phases of lesion pro-
gression and repair. This might have profound implications for
novel neuroprotective strategies that differentially target such
phases (Lo, 2008).
Spreading suppression of LF-VF
The invasiveness of the ECoG recording is a limitation to monitor
CSDs in a larger patient population with stroke, hypoxic encepha-
lopathy or traumatic brain injury. The present study suggests that
imaging the suppression of LF-VF is a promising candidate to
monitor the dynamics of lesion progression in the human brain
non-invasively using technology such as functional MRI or near-
infrared spectroscopy.
The mechanistic basis for spreading suppression of LF-VF is
linked to the term ‘default mode’ that describes the process
whereby the brain remains active in an organized fashion during
rest (Fox and Raichle, 2007). This concept originates from the
ﬁnding that some brain regions are more active at rest than
during task performance (Raichle et al., 2001). CSD provides a
depolarization block of the resting neuronal activity, or, in other
words, of the ‘default mode’. This block is measured in the ECoG
as spreading depression of high-frequency-ECoG activity (Lea ˜o
et al., 1944).
It has been hypothesized that spontaneous ﬂuctuations in the
blood oxygen level dependent (BOLD) signal of functional MRI
are a manifestation of the ‘default mode’. This hypothesis arose
from the coherence of spontaneous BOLD ﬂuctuations recorded in
different motor areas in the absence of overt motor behaviour
(Biswal et al., 1995). The regionally speciﬁc BOLD coherence
was restricted to frequencies below 0.1Hz, whereas higher
frequencies were related to heart-beat or respiration (Cordes
et al., 2001).
The BOLD signal mainly reﬂects local variations in
de-oxyhaemoglobin concentration that result from a combination
of changes in regional cerebral blood ﬂow and/or oxygen metab-
olism. Using arterial spin-labelling perfusion MRI, it was shown
that low-frequency regionally speciﬁc BOLD signal coherences are
reﬂected by similar regionally speciﬁc low-frequency coherences of
regional cerebral blood ﬂow (De Luca et al., 2006). These LF-VF
also persist across different resting states, including anaesthesia,
indicating that they are an intrinsic property of the brain rather
than the result of unconstrained mental activity (Vincent et al.,
2007).
Our ﬁnding that spreading suppression of LF-VF correlated with
spreading depression of high-frequency-ECoG activity is consistent
with the hypothesis that LF-VF require a neuronal input.
Alternatively, LF-VF could originate from ‘vasomotion’, i.e. an
oscillation generated from within the vascular wall without neuro-
nal input. ‘Vasomotion’ could be blocked by CSD (Piper et al.,
1991) if the extracellular changes somehow interfere with the
gap junction communication between vascular smooth muscle
cells. However, this is contradicted by the ﬁnding that vascular
conduction is preserved in mice and rats during CSD (Brennan
et al., 2007). Moreover, cellular swelling could act mechanically
as a high-pass ﬁlter on the microvascular walls during CSD,
thereby blocking ‘vasomotion’ in contrast to HF-VF. However,
the depression periods of the LF-VF were too long in relation to
the measured DC negativities for this mechanism: extracellular
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(Windmu ¨ller et al., 2005). Furthermore, (i) ‘vasomotion’ is typi-
cally enhanced by vasoconstriction (Nilsson and Aalkjær, 2003);
and (ii) Schmidt reviewed the question of whether ‘vasomotion’
occurs at all under physiological conditions and concluded that
‘vasomotion’ is primarily associated with ischaemic conditions in
various vascular beds (Schmidt, 1996). Thus, the suppression of
the LF-VF during CSI in the present study strongly contrasts the
typical behaviour of ‘vasomotion’. Thus, whether LF-VF in the
brain are due to ‘vasomotion’ or require a neuronal input cannot
be conclusively answered, but our ﬁndings strongly support the
latter (Fox and Raichle, 2007).
HF-VF might be used to estimate
the perfusion response to CSD
non-invasively
Pressure and ﬂow amplitudes of the arterial pulse decay along the
branching arterial tree (Gross et al., 1974). This decay of micro-
vascular pulsatility in the high-frequency range is dependent on
the resistance of upstream arterioles. The lower the vascular tone
in upstream arterioles, the higher the downstream high-frequency
pulsatility and vice versa. Consistently, in contrast to LF-VF, the
HF-VF amplitude changed in accordance with perfusion changes
associated with CSD.
The physiological haemodynamic
response to CSD
The physiological haemodynamic response to CSD is characterized
by the hyperperfusion associated with the negative cortical DC
shift followed by a mild hypoperfusion after recovery of the DC
potential. A body of evidence indicates that CSD is primarily a
phenomenon of neurons rather than astrocytes (Basarsky et al.,
1998; Peters et al., 2003; Somjen, 2004). Hence, the physiological
haemodynamic response to CSD seems to result from a coupling
process between neurons and vasculature. Classically, the term
neurovascular coupling describes the increased regional cerebral
blood ﬂow in response to neuronal activation and decreased
regional cerebral blood ﬂow in response to neuronal inhibition
(Devor et al., 2007). It is increasingly recognized that neurotrans-
mitter and neuropeptide release during synaptic transmission
is a major contributor to the neurovascular response (Attwell
and Iadecola, 2002; Hamel, 2006). Neural activation leads to
glutamate-evoked calcium inﬂux in postsynaptic neurons that
activates production of NO and arachidonic acid metabolites.
The resulting vasodilatation reﬂects both the presynaptic activity
and the level of postsynaptic depolarization, which changes the
magnesium block of NMDA receptors and the resulting inﬂux of
calcium (Attwell and Iadecola, 2002).
The physiological haemodynamic response to CSD seems to
conﬂict with this classical deﬁnition of neurovascular coupling,
since an increased regional cerebral blood ﬂow is coupled to
depression of neuronal activity. This paradox is resolved by the
fact that activity depression during CSD results from a depolariza-
tion block of action potential generation. Spreading depression of
high-frequency-ECoG thus reﬂects a form of intense excitation, in
contrast to neuronal inhibition resulting from GABA-mediated
hyperpolarization. CSD shares several additional features in
common with neuronal excitation and in contrast with inhibition:
(i) glutamate is markedly released and, thus, vasoeffectors such as
NO are released as well (Busija et al., 2008); (ii) although the ion
concentration changes during CSD are markedly higher, the direc-
tion of ion ﬂuxes is similar to that during neuronal excitation and
their net effect is vasodilatation (Windmu ¨ller et al., 2005) and
(iii) metabolism and energy demand are increased during CSD
(Mies and Paschen, 1984; Gault et al., 1994). Thus, the physio-
logical response of hyperaemia to CSD is consistent with other
forms of normal neurovascular coupling to depolarization such
as during physiological activation or epileptic activity, despite the
fact that the neuronal excitation during CSD is so intense that
even the ability for action potential generation is lost. As in pre-
vious experimental publications on CSI (Dreier et al., 2002;
Petzold et al., 2003, 2005; Windmu ¨ller et al., 2005), we have
used the term ‘inverse’ haemodynamic response to describe hypo-
perfusion associated with the depolarization phase of CSD since
the normal mechanisms coupling neuronal depolarization, gluta-
mate release and increased energy demand to increased regional
cerebral blood ﬂow are impaired such that they produce the
inverse effect.
The inverse haemodynamic response
to CSD
We found clear evidence of inverse haemodynamic responses
to CSD in our patients: the hypoperfusion was coupled to the
prolonged negative DC shift followed by hyperperfusion after
recovery of the DC potential. CSI showed a continuous spectrum
of up to 144min duration, as in previous animal studies (Dreier
et al., 2000; Shin et al., 2006; Strong et al., 2007). Experimental
evidence suggests that the enormous prolongation of the CSD-
induced initial hypoperfusion is the result of a vicious cycle
between neuronal release of vasoconstrictors such as potassium,
the reduced supply and increased demand for ATP, and the con-
sequent failure of the sodium pump. This latter prevents clearance
of the vasoconstrictor potassium from the extracellular space and
thus maintains the hypoperfusion (Dreier et al., 2002; Sukhotinsky
et al., 2008).
Possible contributors to inverse haemodynamic responses after
aSAH have been discussed previously (Dreier et al., 2000). Brieﬂy,
proximal vasospasm might contribute to CSI in analogy to the
penumbra after MCA occlusion (Shin et al., 2006; Strong et al.,
2007). The NO scavenging effect of haemoglobin in the clot,
endogenous NOS inhibitors or degeneration of perivascular nitrer-
gic nerves might play a role (Dreier et al., 1998; MacDonald et al.,
2007) as well as astrocyte-mediated vasoconstriction (Mulligan
and MacVicar, 2004; Tomita et al., 2005; Chuquet et al., 2007),
increased baseline potassium (Dreier et al., 2000), endothelin-1
(Petzold et al., 2003) and rho-kinase (Shin et al., 2007). ICP
was signiﬁcantly higher during clusters of recurrent CSDs than
during isolated CSDs in our patients. It deserves further study
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clusters and CSI.
Possible interventions targeting CSI
Interestingly, the CSD cluster associated with CSI in Case 1 was
not prevented by the NMDA receptor antagonist (S)-ketamine,
which is consistent with previous animal ﬁndings (Petzold et al.,
2005).
All patients were treated prophylactically with nimodipine
(Pickard et al., 1989; Dorhout et al., 2008). Experimental evidence
has suggested that this L-type calcium antagonist causes CSI to
revert to a more physiological haemodynamic response to CSD
and, thus, may protect the brain (Dreier et al., 1998;
Windmu ¨ller et al., 2005). However, the dose is limited by systemic
side-effects and this might explain why CSIs occurred despite the
presence of nimodipine. Possibly, surgical placement of drug-
containing prolonged-release implants at the basal cerebral arteries
provide a better treatment option, since proximal vasospasm is
prevented more effectively and the cerebrospinal ﬂuid circulation
might transport the drug over the hemispheric surface where
microvascular spasm and CSI are targeted (Barth et al., 2007).
Cerebral glucose may be another target for intervention.
Hyperglycaemia has been associated with worse outcome after
ischaemic stroke (Mohr et al., 1985). However, while glycaemic
control with insulin has been established in intensive care patients
in general surgery (van den Berghe et al., 2001), translation of this
concept into improved clinical management of acute stroke has
failed so far (Gray et al., 2007). Speciﬁcally in aSAH patients,
signiﬁcant associations of low cerebral glucose with unfavourable
outcome and severe cellular distress have been found recently
(increases in lactate/pyruvate ratio, glutamate and glycerol as
measured by cerebral microdialysis) (Schlenk et al., 2008). In the
present study, insulin treatment in Case 1 was associated with a
hypoglycaemic episode that was time-locked to, and possibly trig-
gered, the delayed cluster of recurrent CSDs and CSI on Day 9
after the initial haemorrhage. In the ischaemic penumbra in ani-
mals, even mild reduction in plasma glucose has been associated
with increased frequency of CSDs (Strong et al., 2000), whilst
superfusion of the cortex with solution containing haemoglobin
and low-glucose-induced CSI (Dreier et al., 2000). These ﬁndings
call for a clinical study on glycaemic control after aSAH to deter-
mine the optimal range of plasma glucose. In such a trial the
assessment of patient outcome should be complemented by the
monitoring of ECoG, regional cerebral blood ﬂow, ptiO2 and
metabolism.
Moreover, blockade of chronic vasospasm remains an important
therapeutic objective. Neuromonitoring in a randomized clinical
trial of the endothelin antagonist clazosentan could help us to
understand the possible links between chronic vasospasm and
CSI as well as their relative contributions to ischaemic damage
and patient outcome after aSAH (MacDonald et al., 2007). We
should consider the possibility that only combination therapies
targeting vasospasm, disturbed neuronal function and disturbed
neurovascular coupling might improve patient outcome
signiﬁcantly.
Conclusion
This translational study has established proof of CSI as a novel
pathophysiological mechanism of disease and potential target
for neuroprotective intervention in the human brain. Moreover,
imaging the spreading suppression of LF-VF is suggested as a
promising tool to differentiate between progressive ischaemic
damage and repair phases in the human brain non-invasively.
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